Top videos
Anterior vaginal wall relaxation (cystocele) is one of the most commonly diagnosed forms of pelvic organ prolapse in women. More than 200,000 cystocele repairs are completed yearly, however to date the procedures that are completed do not provide very high cure rates and/or poor anatomic outcomes. Successful treatment of anterior vaginal wall prolapse remains one of the most challenging aspects of pelvic reconstructive surgery we face. We have developed very good procedures that provide excellent support for the posterior wall (ie rectoceles) and the apex of the vagina (ie vaginal vault prolapse) and reproduce normal anatomy. We were one of the first centers in the country to utilize grafts in rectocele repairs and have seen improved cure rates to over 90% with minimal complications. It has been known for many years that abdominal sacralcolpopexy with placement of a mesh graft at the top of the vagina for vaginal vault prolapse is the most successful procedure in the literature. We have made advancements with this procedure as well in being able to offer our patients a laparoscopic minimally invasive approach for sacralcolpopexy, with the same excellent cure rates (>92%) and with hospital stays typically less than 24 hours and reduced complications. However the anterior wall has been one of the most difficult compartments in the vagina to get good anatomic results and high cure rates with traditional repairs and at the same time not cause sexual dysfunction, pain with intercourse, voiding dysfunction (ie incontinence or urgency/frequency syndrome), or a shortened or scarred down vagina. The transobturator approach was developed as a less invasive way to place an anterior wall graft (see below) however this still involved blind needle passes and the graft did not support the apex of the vagina, therefore the search for improvements in these procedures is ongoing.
The Closure Procedure for Varicose Veins is a clinically proven, minimally invasive procedure that treats varicose veins and their underlying cause, venous reflux, with little or no pain. Closure patients can walk away from the vein procedure and be back to everyday activities – either at home or at work – typically within a day.
Insight eNO has revolutionized asthma treatment. Apieron’s asthma products as shown in this demo in AARC (American Association for Respiratory Care)help in managing asthma for patients suffering from acute asthma attacks by detecting exhaled nitric oxide (eNO) present in the human breath.
avara plastic surgery center in Cairo Egypt where you can have amazing excellent surgery with very competitive price and at the same time spend your marvelous vacation in charming red sea
مركز افارا لجراحات التجميل في مصر هو مركز متخصص في جراحة التجميل بكافة فروعها تصغير المؤخرة تصغير الارداف تنسيق القوام شد المؤخرة و جراحة الثدي تكبير الثدي تكبير الصدر تجميل الثدي تجميل الصدر شد الثدي شد الصدر تصغير الثدي تصغير الصدر رفع الثدي رفع الصدر شد الترهلات شد الجسم شد البطن شد الارداف شد المؤخرة رفع المؤخرة تجميل الانف تصغير الانف زراعة الشعر شد الجفون تجميل الجفن تجميل العين شد الوجة تجميل الاذن شفط الدهون شفط الشحوم بالليزر تصغير الساق نحت الجسم ازالة الشعر بالليزر علاج الهالات السوداء تجميل الوجة تجميل البشرة تجميل الجسم بدون جراحة حقن الدهون نفخ الوجة حقن السيايكون جقن الفيليرز حقن البوتكس علاج تجاعيد الوجة تقوية الشعر تكبير الخدود تكبير الشفايف
Cisplatin is in a class of drugs known as platinum-containing compounds used to treat various types of cancers including metastatic testicular and ovarian tumors. The molecule was first discovered in 1845, but did not receive FDA approval until 1978. Today it is known as the "penicillin of cancer drugs," because it is so effective for many different cancers. There are three key players involved in Cisplatin's mechanism: (1) Cisplatin, (2) DNA (3) and an HMG Protein. Most Cisplatin enters the body through active transport, but some molecules are passively defused through the cell membrane. Once in the nucleus, Cisplatin can form an adduct with two consecutive guanine bases within a strand of DNA. The molecule loses its chlorine atoms in exchange for the nitrogen atoms of the target guanines. Cisplatin can bond more tightly with nitrogen because nitrogen balances the platinum charge more effectively than chlorine. It is this adduct-induced DNA bend that allows binding of proteins which contain the high mobility group, HMG domain. Once the protein is bound to the DNA, it inserts a wedge-like phenyl group of phenylalanine 37 into the widened minor groove created by the bend. The tightly bound HMG protein causes destacking of the nucleotide bases, resulting in the DNA helix becoming kinked. In this way, Cisplatin can be thought of as a monkey wrench in the DNA repair system. With the HMG protein bound to the DNA, the modified strand is not repaired properly and so the cell dies. The success of Cisplatin depends on its ratio of efficacy between cancerous and healthy cells.